Eli Lilly & Co. said it will press ahead with global drug launches despite uncertainty over the Trump administration’s ...

Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced that Japan's Ministry of Health, Labour and Welfare (MHLW) ...

A consensus has been growing in the Japanese pharmaceutical industry that it”s time to get serious about competing in the U.S. market. The latest affirmation came earlier this month when Yamanouchi ...

With China's growing dominance in the biopharma sector as a hotspot for drug asse | A group of over 20 global pharma leaders ...

The Japanese drugmaker that sells rare-disease medicine Tavneos said new patients will be able to get the drug, which carries ...

Amid a suspected hantavirus outbreak on a cruise ship, Japan's health minister says Japan has provided the anti-influenza ...

Japan’s pharmaceutical sector is gradually reorienting from deep, validation-led development towards execution-driven ...

Japan has formally approved the world’s first regenerative medical products utilizing induced pluripotent stem (iPS) cells, ...

Japan mirrors Europe’s pharma challenge, with its share of global drug approvals and clinical trials declining ...

A Japanese pharmaceutical firm has warned doctors against prescribing a drug for rare autoimmune diseases to new patients ...

Sales of the problematic Amgen Inc. drug Tavneos resumed late last week in Japan with a new warning label after several ...

Unlike Tom Waits, drugs are not big in Japan. The Japanese have some of the lowest rates of drug use of any Western-style democracy with a powerful economy. How low? At one point in the mid-1980s, ...